TW202408516A - 液體組成物 - Google Patents

液體組成物 Download PDF

Info

Publication number
TW202408516A
TW202408516A TW112115225A TW112115225A TW202408516A TW 202408516 A TW202408516 A TW 202408516A TW 112115225 A TW112115225 A TW 112115225A TW 112115225 A TW112115225 A TW 112115225A TW 202408516 A TW202408516 A TW 202408516A
Authority
TW
Taiwan
Prior art keywords
aqueous composition
pharmaceutically acceptable
acceptable salt
rilpivirine
hyaluronidase
Prior art date
Application number
TW112115225A
Other languages
English (en)
Chinese (zh)
Inventor
賽門 維奇
米萊安 科隆波
安 德瑟格
馬欣 維斯崔頓
伊溫 維沃特
Original Assignee
愛爾蘭商健生科學愛爾蘭無限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 愛爾蘭商健生科學愛爾蘭無限公司 filed Critical 愛爾蘭商健生科學愛爾蘭無限公司
Publication of TW202408516A publication Critical patent/TW202408516A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW112115225A 2022-04-22 2023-04-24 液體組成物 TW202408516A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263333556P 2022-04-22 2022-04-22
US63/333,556 2022-04-22
EP22173922 2022-05-17
EP22173922.0 2022-05-17

Publications (1)

Publication Number Publication Date
TW202408516A true TW202408516A (zh) 2024-03-01

Family

ID=86316741

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112115225A TW202408516A (zh) 2022-04-22 2023-04-24 液體組成物

Country Status (7)

Country Link
US (1) US20250268896A1 (cg-RX-API-DMAC7.html)
EP (1) EP4511003A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025513502A (cg-RX-API-DMAC7.html)
CN (1) CN119403543A (cg-RX-API-DMAC7.html)
CA (1) CA3249515A1 (cg-RX-API-DMAC7.html)
TW (1) TW202408516A (cg-RX-API-DMAC7.html)
WO (1) WO2023203258A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
EP2330213A1 (en) 2003-03-05 2011-06-08 Halozyme, Inc. Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
PT3366278T (pt) 2006-06-23 2024-10-21 Janssen Sciences Ireland Unlimited Co Suspensões aquosas de tmc278
WO2009128917A2 (en) * 2008-04-14 2009-10-22 Halozyme, Inc. Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
AU2020344675B2 (en) * 2019-09-13 2026-06-25 Halozyme Hypercon, Inc. Compositions and methods for the delivery of therapeutic biologics for treatment of disease
WO2022109555A1 (en) 2020-11-17 2022-05-27 Janssen Sciences Ireland Unlimited Company Treatment or prevention of hiv infection

Also Published As

Publication number Publication date
EP4511003A1 (en) 2025-02-26
CN119403543A (zh) 2025-02-07
WO2023203258A1 (en) 2023-10-26
CA3249515A1 (en) 2023-10-26
US20250268896A1 (en) 2025-08-28
JP2025513502A (ja) 2025-04-24

Similar Documents

Publication Publication Date Title
EP3366278B1 (en) Aqueous suspensions of tmc278
JP2009507925A (ja) ナノ粒子タダラフィル製剤
US20250268896A1 (en) Liquid compositions
US20250275967A1 (en) Freeze dried compositions
KR101811314B1 (ko) Hiv 감염의 치료 및 예방
TW202408526A (zh) 治療或預防hiv感染(一)
AU2016219555B2 (en) Aqueous suspensions of TMC278
TW202333725A (zh) 溶出測試
CN119968203A (zh) 长效配制品
TW202233192A (zh) Hiv感染之治療或預防
CN118251210A (zh) 溶出测试
CN116437923A (zh) Hiv感染的治疗或预防
HK1129586B (en) Aqueous suspensions of tmc278
HK1129586A (en) Aqueous suspensions of tmc278